Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells

被引:541
作者
Nilsson, SK
Johnston, HM
Whitty, GA
Williams, B
Webb, RJ
Denhardt, DT
Bertoncello, I
Bendall, LJ
Simmons, PJ
Haylock, DN
机构
[1] Peter MacCallum Canc Ctr, Stem Cell Res Lab, Melbourne, Vic 3000, Australia
[2] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA
[3] Canc Inst New Jersey, Piscataway, NJ USA
[4] Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Sydney, NSW 2006, Australia
关键词
D O I
10.1182/blood-2004-11-4422
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although recent data suggests that osteoblasts play a key role within the hematopoietic stem cell (HSC) niche, the mechanisms underpinning this remain to be fully defined. The studies described herein examine the role in hematopoiesis of Osteopontin (Opn), a multidomain, phosphorylated glycoprotein, synthesized by osteoblasts, with well-described roles in cell adhesion, inflammatory responses, angiogenesis, and tumor metastasis. We demonstrate a previously unrecognized critical role for Opn in regulation of the physical location and proliferation of HSCs. Within marrow, Opn expression is restricted to the endosteal bone surface and contributes to HSC transmarrow migration toward the endosteal region, as demonstrated by the markedly aberrant distribution of HSCs in Opn(-/-) mice after transplantation. Primitive hematopoietic cells demonstrate specific adhesion to Opn in vitro via beta(1) integrin. Furthermore, exogenous Opn potently suppresses the proliferation of primitive HPCs in vitro, the physiologic relevance of which is demonstrated by the markedly enhanced cycling of HSC in Opn(-/-) mice. These data therefore provide strong evidence that Opn is an important component of the HSC niche which participates in HSC location and as a physiologic-negative regulator of HSC proliferation.
引用
收藏
页码:1232 / 1239
页数:8
相关论文
共 57 条
  • [1] Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin)
    Agnihotri, R
    Crawford, HC
    Haro, H
    Matrisian, LM
    Havrda, MC
    Liaw, L
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) : 28261 - 28267
  • [2] Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche
    Arai, F
    Hirao, A
    Ohmura, M
    Sato, H
    Matsuoka, S
    Takubo, K
    Ito, K
    Koh, GY
    Suda, T
    [J]. CELL, 2004, 118 (02) : 149 - 161
  • [3] Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone
    Asou, Y
    Rittling, SR
    Yoshitake, H
    Tsuji, K
    Shinomiya, K
    Nifuji, A
    Denhardt, DT
    Noda, M
    [J]. ENDOCRINOLOGY, 2001, 142 (03) : 1325 - 1332
  • [4] Bone marrow subendosteal microenvironment harbours functionally distinct haemosupportive stromal cell populations
    Balduino, A
    Hurtado, S
    Frazao, P
    Takiya, CM
    Alves, LM
    Nasciutti, LE
    El-Cheikh, MC
    Borojevic, R
    [J]. CELL AND TISSUE RESEARCH, 2005, 319 (02) : 255 - 266
  • [5] A regulated interaction between α5β1 integrin and osteopontin
    Barry, ST
    Ludbrook, SB
    Murrison, E
    Horgan, CMT
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 267 (03) : 764 - 769
  • [6] BARTELMEZ SH, 1989, EXP HEMATOL, V17, P240
  • [7] Bayless KJ, 1998, J CELL SCI, V111, P1165
  • [8] A monoclonal antibody recognizing CD43 (leukosialin) initiates apoptosis of human hematopoietic progenitor cells but not stem cells
    Bazil, V
    Brandt, J
    Chen, S
    Roeding, M
    Luens, K
    Tsukamoto, A
    Hoffman, R
    [J]. BLOOD, 1996, 87 (04) : 1272 - 1281
  • [9] Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines
    Bigas, A
    Martin, DIK
    Milner, LA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (04) : 2324 - 2333
  • [10] Bradford GB, 1997, EXP HEMATOL, V25, P445